Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular Events in Community Population(PICC Study)

NCT04212520 | Recruiting

• 1 other identifier: 2018150H(R2)
• Study Type: observational
• Target: 6,500
• Locations: 1 country
• Sites: 1

Brief Summary

Numerous studies have shown that non-fasting blood lipid levels are closely related to the occurrence of cardiovascular and cerebrovascular events, but it is still unclear in the Chinese population. The purpose of the study is to investigate the association between non-fasting blood lipid levels and adverse outcomes in Chinese community population.

Conditions

Lipid

Keywords

non-fasting lipid; cardiovascular and cerebrovascular events; major adverse cardiovascular events

Outcome Measures

Primary Outcomes (3)

• All-cause mortality

  All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.

  Through study completion, an average of 1 years

• Cardiovascular Mortality

  Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).

  Through study completion, an average of 1 years

• Cardiovascular and cerebrovascular diseases

  The number of and the incidence rate of cardiovascular and cerebrovascular diseases.

  Through study completion, an average of 1 years

Interventions

No intervention OTHER

No intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study population includes subjects who living in community, of any race or ethnicity, 18 or older years of age, and have provided written informed consent.

You may qualify if:

• ≥18 years old;
• Signed informed consent;
• Life expectancy is greater than 1 year.

You may not qualify if:

• mental disorder;
• is not willing to participate in the clinical study;
• suffered with other disease to quite the trial;
• violated the protocol.

Sponsors & Collaborators

• Guangdong Provincial People's Hospital: lead

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510080, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

This study will collect 20 mL whole blood samples from subjects at one or more study visits. The whole blood will be processed to plasma and stored for testing.

Study Officials

• Feng Ying-qing, PhD

  Guangdong Provincial People's Hospital

  STUDY CHAIR

Central Study Contacts

Feng Ying-qing, PhD

CONTACT

+862083827812; 651792209@qq.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 24, 2019
• First Posted: December 27, 2019
• Study Start: January 1, 2020
• Primary Completion: December 31, 2023
• Study Completion (Estimated): December 31, 2050
• Last Updated: January 13, 2020

Record last verified: 2019-12

Locations

CN (1)